Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-30T06:41:10.549Z Has data issue: false hasContentIssue false

Quetiapine-induced neuroleptic malignant syndrome

Published online by Cambridge University Press:  16 April 2020

R.M. Freire Lucas*
Affiliation:
Coimbra University Hospitals, Coimbra, Portugal

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Neuroleptic Malignant Syndrome (NMS) is the most serious of acute neurological side effects produced by antipsychotic medication, the prevalence of which varies from 0,4–1,4%. It is typically characterized by hyperthermia, rigidity, altered consciousness and autonomic dysfunction. NMS is induced less by atypical antipsychotics than by conventional antipsychotics, and one particular atypical antipsychotic - quetiapine - rarely causes NMS. In this work, we describe a case of quetiapine-induced NMS, while reviewing the recent literature on this condition.

We searched for scientific articles about this topic on the databases MEDLINE, LILACS and PsycINFO, using the search words “neuroleptic malignant syndrome” and “quetiapine”. We chose to preferentially include original articles and recent reviews, or those considered classical articles in the scientific literature.

Type
P03-70
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.